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Abstract
During the last twenty years, the research in
nanoscience and nanotechnology has dramati-
cally increased and, in the last decade, the
interest has progressively been oriented
towards biomedical applications, giving rise to
a new field termed nanomedicine. Transmis -
sion electron microscopy is a valuable tech-
nique not only for the thorough physico-chem-
ical characterization of newly synthesized
nanoparticulates, but especially to explore the
effects of nanocomposites on biological sys-
tems, providing essential information for the
development of efficient therapeutic and diag-
nostic strategies. Thus, for the progress of
nanotechnology in the biomedical field,
experts in cell biology, histochemistry and
ultramicroscopy should always support the
chemists, physicists and pharmacologists
engaged in the synthesis and characterization
of innovative nanoconstructs.
Introduction
During the last twenty years, the research in
nanoscience and nanotechnology has dramati-
cally increased with more than 115,000 articles
published in qualified journals since 1995; in
the last decade, the interest has progressively
been oriented towards biomedical applications
(Figure 1), giving rise to a new field termed
nanomedicine. 
A plethora of nanoparticulates have been
experimented for different applications: as
drug delivery systems, contrast agents for in
vivo imaging, sensors to specifically detect
cells or organic components in the living body,
sorting systems, scaffold components for  tis-
sue engineering, and many other innovative
uses.1-5 The great versatility of nanomaterials
offers, in fact, special advantages in biomedi-
cine: their size (1 to 100 nm) approaches the
biomolecular scale, facilitating their interac-
tions with the biological environment; in addi-
tion, they can be made of organic, inorganic or
both materials, and assume various configura-
tions (spheres, shells, rods, dishes, prisms,
cubes, etc.), making them suitable tools for
multiple purposes. Moreover, their surface can
be functionalized allowing the targeting to spe-
cific cell types.6,7
Transmission electron microscopy (TEM) is
a valuable technique for the thorough physico-
chemical characterization of newly synthe-
sized nanoparticulates; actually, during the
last ten years, more than 15,000 articles on
nanoparticles include TEM among the used
methods (https://www.ncbi.nlm.nih.gov/
pubmed/). TEM is also recently becoming a
technique of choice to explore the effects of
nanocomposites on biological systems: on a
total of about 6,500 scientific articles on this
subject in the last ten years, 2,400 (37%) were
published from 2014 to 2016.
Generally, nanovectors are first tested using
in vitro cultured cells, which ensures simple
and controlled conditions as well as short
experimental times; this also implies signifi-
cantly reduced costs for the preliminary char-
acterization of nanovectors, and a reduction in
the number of laboratory animals for the fol-
lowing in vivo studies aimed at verifying their
systemic suitability. 
The first step of safety assessment of nano-
materials for biomedical use must encompass
not only cell death evaluation but also any cell
stress or damage at short, medium and long
term, since cell necrosis or apoptosis may trig-
ger an inflammatory response in the organism
of the patient receiving the nanoparticulate
system.8,9 Moreover, the localization and
dynamic tracking of nanoparticulates inside
the cells and tissues represent an essential
information to design efficient administration
strategies. Ultrastructural studies can profi-
ciently be used to this aim.
Ultrastructural morphology fornanotechnology 
To play their therapeutic or diagnostic func-
tion, nanoconstructs must interact with the
biological environment, in primis with the cell.
It is mandatory to know their behavior, from
their ability to cross the plasma membrane, to
their intracellular traffic up to their degrada-
tion route. 
Thanks to its high resolution, TEM can pro-
vide unequivocal information on the uptake
mechanism(s): nanocarriers have been
observed making contact with the plasma
membrane -either singly or as small groups-
and entering the cell by endocytic processes; in
the presence of large clusters of nanoparticu-
lates, some cells are able to protrude
pseudopods and internalize the clusters by
phagocytosis; other nanovectors, especially of
lipid nature, have been found to pass the bio-
logical membranes by fusion, thus avoiding
the endosomal route.10-21 These different
uptake mechanisms entail important function-
al consequences. In fact, endocytosis-mediated
internalization, especially when receptors are
involved, may reflect a limited uptake capabili-
ty and a consequently low/slow intracellular
accumulation of nanovectors. This is particu-
larly true when nanocarriers are internalized
as single units. On the other hand, phagocyto-
sis (which often occurs together with endocy-
tosis) allows high amounts of nanoparticulates
to enter the cell, giving often rise to large cyto-
plasmic inclusions. Finally, membrane cross-
ing by lipid raft-mediated endocytosis leads to
a rapid and massive entrance of nanoparticu-
lates, as a consequence of hydrophobic inter-
nalization through lipid membrane fusion or
by uptake of lipophilic and anionic groups via
scavenger receptor-mediated membrane
fusion.22
These features must be taken into consider-
ation when planning to use nanovectors, for
example, as drug carriers or contrast agents or
signaling systems. In particular, lipid rafts are
typical of many human tumor cells,23,24 thus
representing a potential advantage for the
therapeutic/diagnostic utilization of lipid
nanovectors. 
It is worth noting that some nanoparticles
may adhere each other through electrostatic or
other binding interactions, and this may obvi-
ously affect their capability to be internalized
by cells:12,16 TEM can provide information on
these interactions, provided that the appropri-
ate procedures for sample fixation and embed-
ding are used to preserve the nanoparticles or
nanoparticle clusters at the cell surface as well
as in the extracellular space.
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The uptake mechanism strongly affects the
intracellular fate of the nanoparticulates. In
fact, the entrapment into endosomes (as it
occurs when internalization is endocytosis- or
phagocytosis-mediated) implies that internal-
ized nanovectors will follow the endolytic
route, undergoing degradation by the lysoso-
mal enzymes.25 Some nanomaterials (especial-
ly cationic polymers) are able to escape endo-
somes due to a “proton sponge effect” which
leads to the rupture of the nanoparticulate-
entrapping vacuole;26 this event does not gen-
erally induce cell damage probably because of
the inability of lysosomal enzymes to be active
at the cytosolic neutral pH, or due to the rapid
repair of the vesicle membrane preventing the
efflux of lysosomal enzymes after the nanopar-
ticles had been released. 
Through this phenomenon, nanoparticu-
lates may occur free in the cytosol and escape
lysosomal degradation. When present free in
the cytosol, nanoparticles can interact with
cytoplasmic organelles possibly interfering
with their functions. Free cytosolic nanoparti-
cles have been demonstrated to enter the
nucleus,27-32 either by passing through the
nuclear pores33 or being entrapped in the
nuclear envelope when it reassembles at the
end of mitosis;34 anyway, this event may have
unpredictable consequences on the nucleus-
driven cell activity. Generally, after a more or
less prolonged period, cytosolic nanovectors
are enclosed in autophagosomes; thus they re-
enter the lytic pathway and either undergo
degradation or give rise to residual bodies,
whose intracellular persistence depends on
nanoparticulate amount and biodegradabili-
ty.12,13,30,35,36 TEM provides detailed information
on these events allowing to identify the differ-
ent steps of the intracellular pathways and,
importantly, to distinguish the presence of
intact nanovectors or their remnants after
enzymatic lysis: this latter finding is important
to accurately describe the intracellular perma-
nence of nanoparticles which cannot be prop-
erly obtained by light (namely confocal fluores-
cence) microscopy. 
Nanovectors immediately occur free in the
cytosol when they enter the cells by route other
than the endosomal one, and they may persist
therein for variable periods before undergoing
autophagy and enzymatic degradation.
Interestingly, ultrastructural observations
recently allowed the visualization of the rapid
cytosolic disassembly of liposomes shortly
after their uptake:12 liposome components
accumulate inside the lipid droplets (probably
due to chemical affinity) and are finally
extruded from the cells as lipid remnants. 
In the case of drug-delivering nanocarriers,
data on their intracellular persistence and
degradation are useful to predict the fate of the
loaded molecules and, therefore, to plan treat-
ment strategies ensuring appropriate avail-
ability and sustainability of the
therapeutic/diagnostic agents. Moreover, the
intracellular persistence of free nanoparticu-
lates or their remnants must be carefully con-
sidered for the evaluation of cell stress, espe-
cially when multiple administrations are
planned. 
When nanoconstructs are tested ex vivo or
in vivo, the fine analysis of their distribution
in the different tissues becomes crucial to plan
their biomedical application: the identification
of the tissue components where the nanocom-
posites localize (i.e., specific cell types, the
amorphous or fibrillar components of the
extracellular matrix, the blood vessels, etc.) is
important to evaluate the capability of the
nanovectors to reach the expected biological
target and, consequently, to predict its poten-
tial therapeutic/diagnostic role. In particular,
the ability to cross the biological barriers is
crucial to select the most suitable administra-
tion routes and protocols (concentrations,
doses, etc.). It is in fact known that a signifi-
cant number of newly synthesized nanocom-
posites successfully tested in in vitro models
proved to be unsuitable when applied in vivo
because of the systemic defense.37
In addition to nanovectors tracking, TEM
play a key role in the identification of cell
structural and molecular alterations induced
by the nanoparticulate: membrane breakage,
mitochondria swelling or shrinkage, changes
in the length or shape of the mitochondrial
cristae, reorganization of the endoplasmic
reticulum and Golgi apparatus, rearrangement
of the nuclear domains are all undetectable
features at the lower resolution of light
microscopy. 
Beyond ultrastructural morphology
The visualization of nanomaterials at TEM
depends on their chemical composition.
Nanoparticulates containing heavy atoms are
more electron dense than those containing
atoms of lower mass. Consequently, inorganic
nanoconstructs (e.g., gold, silver, iron oxide
nanoparticles, silica-based nanoparticles) are
easily detectable inside cells and tissue due to
their intrinsically high electron density and do
not need any particular staining procedure to
enhance their contrast. On the other hand,
nanoparticles made of organic material (e.g.
lipid, chitosan, poly(lactic-co-glycolic acid),
albumin) are characterized by a moderate
electron density that makes them hardly dis-
tinguishable in the cytosol or inside the lysoso-
mal compartments. Lipid-based nanocon-
structs can be easily made more electron
dense by osmium tetroxide post-fixation. To
unequivocally detect polymeric and proteina-
ceous nanoparticles in the intracellular milieu,
the problem can be overcome by applying his-
tochemical procedures for the photo-oxidation
of diaminobenzidine (DAB): this technique
allows to convert the fluorescent signal of fluo-
rochromes into a stable electron dense, finely
granular reaction product visible at the high
spatial resolution of TEM.38 This method
proved to be so efficient to enable detecting
fluorescently labelled nanoparticles even
inside residual bodies (i.e., after the lytic
action of lysosomal enzymes had transformed
the nanoparticles into morphologically unrec-
ognizable remnants).11,13,39 DAB photo-oxida-
tion has been applied so far to nanocomposites
                                                                                             Views and Comments
Figure 1. Number of articles on nanotechnology during the last twenty years (from the
Web of Science database).
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synthesized with fluorescent components (e.g.,
fluorescein isothiocyanate, Nile red or rho-
damine), but its application may be foreseen
also for autofluorescing nanocomposites.40-44
Nanoparticles have been unambiguously
identified at the ultrastructural level also by
means of correlative microscopy approaches:
advanced TEM methods (conventional,
immuno and energy-filtered electron
microscopy, and electron tomography) were
used in combination with light microscopy to
analyze the distribution of different nanoparti-
cles in tissues and cells;45 fluorescence and
electron microscopy (TEM and scanning trans-
mission electron microscopy, STEM) allowed
the ultrastructural identification of quantum
dots inside fibroblasts46 and human pathologi-
cal tissues;47 interferometric photo-activated
localization microscopy and electron
microscopy were correlated to describe the
intracellular distribution of gold nanoparti-
cles;48 correlative optical microscopy and scan-
ning electron microscopy (SEM) were used to
locate gold-core nanoparticles in brain
tumors;49 cryo-soft X-ray tomography provided
information on three-dimentional interactions
of super-paramagnetic iron oxide nanoparti-
cles with breast cancer cells;50 uptake and
intracellular distribution within breast cancer
cells of ZnO-based nanoparticles were
analysed combining dynamic confocal imag-
ing, low resolution bright field TEM and dark
field STEM;51 TEM and Serial Block Face SEM
(SBF SEM) were used to quantify the intracel-
lular uptake of quantum dots.18
Nanoparticles have been demonstrated to be
easily detectable after DAB photo-oxidation
not only in biological samples processed for
conventional fine morphology (aldehyde fixa-
tion, osmium tetroxide post-fixation and epoxy
resin embedding), but also for ultrastructural
cytochemistry and immunocytochemistry
(aldehyde fixation and acrylic resin embed-
ding), and DAB photo-oxidation was demon-
strated to be successfully combined with
immunoelectron microscopy.52
Therefore, the contribution of TEM to the
development of biomedical nanotechnology is
not limited to the conventional morphological
approach aimed at precisely localizing the
nanoparticulates, but encompasses molecular
analyses in situ, which enables evaluation of
functional effects of nanoconstructs adminis-
tration.
Concluding remarks
The widespread application of ultrastructur-
al analyses in nanotechnology clearly demon-
strates the great (still only partially exploited)
potential of electron microscopy in this field.
Looking at the scientific literature, most of
the newly synthesized nanoconstructs for bio-
medical use have been aimed at treating can-
cer (about 22,000 peer reviewed scientific arti-
cles in the last ten years; https://www.ncbi.
nlm.nih.gov/pubmed/); in these investigations,
light (brightfield and fluorescence)
microscopy was often exclusively used to
assess the efficacy of nanoparticle administra-
tion, based on the occurrence of cell death or
tissue necrosis. The ultrastructural reports in
the literature are less numerous, and most of
them are strictly morphological and focused on
the spatial relationships of nanoconstructs
with the plasma membrane or the cytoplasmic
organelles, as the causal events for cell dam-
age and death. 
It is worth noting that the informational
capacity of TEM is much greater, especially
when cytochemical techniques are used to elu-
cidate dynamic cellular processes53-55 or to spa-
tially localize single molecules or molecular
complexes.56,57 This approach would especially
be convenient for studying the effects of
nanovector-based therapies aimed at curing
diseased cells which are to be preserved and
functionally repaired (e.g. highly differentiated
non-cycling cells such as myofibres and neu-
rons, in muscular or neurodegenerative dis-
eases); indeed, ultrastructural cytochemistry
enables to finely describe the cellular morpho-
functional changes induced by drug-delivering
nanovectors, providing evidence for the
restored healthy features and for the possible
occurrence of undesired negative side-effects.
To properly describe the cellular post-treat-
ment events, it is crucial the selection of the
most suitable cell model systems, the appropri-
ate procedures for the preparation of micro-
scopical samples, and the specific histochemi-
cal analyses to be used. Thus, for the progress
of nanotechnology in the biomedical field,
experts in cell biology, histochemistry and
ultramicroscopy should always support the
chemists, physicists and pharmacologists
engaged in the synthesis and characterization
of innovative nanoconstructs.
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